Successful Treatment of Refractory and Relapsed CNS Acute Lymphoblastic Leukemia With CD-19 CAR-T Immunotherapy: A Case Report

In recent decades, survival was significantly improved in B cell acute lymphoblastic leukemia (B-ALL) patients. But refractory and relapsed B-ALL still has aggressive clinical behavior and poor prognosis. Especially, the patients with central nervous system infiltration is very difficult to achieve...

Descripción completa

Detalles Bibliográficos
Autores principales: Htun, Kyaw Thu, Gong, Qiang, Ma, Le, Wang, Ping, Tan, Ya, Wu, Guangsheng, Chen, Jieping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427303/
https://www.ncbi.nlm.nih.gov/pubmed/34513679
http://dx.doi.org/10.3389/fonc.2021.699946

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427303/
https://www.ncbi.nlm.nih.gov/pubmed/34513679
http://dx.doi.org/10.3389/fonc.2021.699946

Ejemplares similares